Loading clinical trials...
Loading clinical trials...
Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Randomized Double Blinded Placebo Cross-over Study in the Pediatric Pain Population
Conditions
Interventions
OnabotulinumtoxinA
Placebo (Saline)
Locations
2
United States
Gottschalk Medical Plaza
Irvine, California, United States
UC Irvine Medical Center
Orange, California, United States
Start Date
March 1, 2017
Primary Completion Date
November 30, 2018
Completion Date
April 20, 2020
Last Updated
October 18, 2023
NCT03986021
NCT04715685
NCT07170176
NCT03268824
NCT06481644
NCT05480930
Lead Sponsor
University of California, Irvine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions